We constructed three CCTs (A–C; Figure 5A–5C) using human adenocarcinoma cells (culture LS174T, European Collection of Cell Cultures), which have a mutation in a key MMR gene [46] and high MS mutation rates [47]. This evidence concerns the gene MRC1 and adenocarcinoma.